Efficacy and Safety of PERIOGEN in the Treatment of Periodontal Bone Defect

NCT00496847 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Intrabony Periodontal Defect

Interventions

DRUG: PERIOGEN
DRUG: Beta TCP alone

Sponsor

Virchow Group